Medical Cannabis Advocacy in North Africa During the 1920s

Cannabis in North African medicine and life before 1920

By the start of the 20th century, cannabis preparations were woven into North African medical and daily practice. In Morocco, kif—chopped cannabis flower mixed with tobacco—was smoked widely, and majoun (a cannabis confection) had documented traditional use for pain, appetite, and sleep ^[1]. In Egypt, hashish had circulated for centuries and appeared in Arabic medical literature as both a recreational intoxicant and a therapeutic agent ^[2]. European pharmacopoeias of the late 19th century also listed Cannabis indica extracts, often sourced from India but conceptually linked to the same plant used across the Maghreb ^[3] Strong evidence.

When the 1920s opened, cannabis was simultaneously a folk medicine, a Western pharmaceutical ingredient, and—increasingly—a public-order concern for colonial administrations in French North Africa and British-occupied Egypt. This tension between traditional use, Western regulation, and emerging prohibitionism would define the decade's politics.

Egypt and Mohamed El Guindy's push for international control

The most consequential North African voice of the decade belonged not to a medical advocate but to a prohibitionist. At the 1924–1925 Second Opium Conference in Geneva, Egyptian delegate Mohamed El Guindy argued that hashish caused widespread insanity and social decay in Egypt and demanded cannabis be added to the international control regime ^[4]. His claims drew heavily on reports from Egyptian mental hospitals, particularly the Abbassia asylum, whose superintendents linked hashish use to patient admissions ^[5] Disputed.

Historian Liat Kozma has shown that these statistics were methodologically weak and shaped by colonial assumptions about causation ^[5]. Hospital admission rates conflated correlation with causation and did not account for socioeconomic factors, other drug use, or diagnostic bias common in colonial-era psychiatry. Despite these limitations, El Guindy's intervention was persuasive.

Delegates from India and the Netherlands offered substantive pushback. They cited the 1894 Indian Hemp Drugs Commission Report, which had concluded that moderate cannabis use was not comparable to opium addiction and found no strong causal link between moderate use and insanity ^[7] Strong evidence. They argued that cannabis should not be treated as a narcotic equivalent to morphine or cocaine. However, these objections were outvoted. El Guindy's framing prevailed in the negotiating committees, and the 1925 International Opium Convention added "Indian hemp" to the schedule of controlled substances, restricting it to medical and scientific use ^[6] Strong evidence.

This is often mislabeled in popular discourse as an outright global ban; it was not. It was an export-control and prescription framework that nonetheless set the trajectory for national prohibitions over the following decades.

Medical voices defending cannabis in North Africa

Genuine medical advocacy for cannabis in 1920s North Africa was limited and came from two distinct sources.

Colonial medical observation. French colonial physicians in Tunisia and Morocco documented traditional therapeutic uses in medical bulletins and journals without necessarily endorsing prohibition. Reports in publications such as the Bulletin de l'Institut d'Hygiène du Maroc recorded kif and majoun being used for asthma, dysentery, and menstrual pain ^[1] Weak / limited. These were ethnographic observations and clinical records rather than organized advocacy campaigns or clinical trials. The physicians reported what they observed among the local population but did not mount a defense against international control efforts.

International rather than North African pushback. The substantive medical and pharmacological counterweight to El Guindy came from Indian colonial administrators and Dutch delegates, not from North African medical professionals. These delegates invoked the 1894 Hemp Commission and argued for a distinction between moderate use and addiction ^[7] Strong evidence. This was the only organized medical-scientific voice at Geneva that opposed cannabis scheduling during the 1925 negotiations.

What did not exist. There was no organized North African medical cannabis movement in the 1920s in any form comparable to modern advocacy. No professional medical societies championed cannabis therapeutics. No clinical trial programs tested cannabis efficacy. No coordinated lobbying against international control emerged from North African medical establishments. Traditional healers continued to prescribe cannabis preparations, but this remained informal practice, undocumented in formal medical literature and unrepresented at diplomatic conferences.

Morocco, Algeria, Tunisia: three different regulatory paths

French colonial policy toward cannabis diverged significantly across North Africa, complicating any single narrative.

Morocco. French authorities took a pragmatic economic approach rather than a prohibitionist one through most of the 1920s. The Régie des Kifs et Tabacs, established under the French Protectorate, maintained a state monopoly on kif production and sale—effectively a licensed, taxed cannabis market—that operated into the 1950s ^[8] Strong evidence. This was economic and fiscal policy rather than medical policy, but it meant Moroccan cannabis was regulated as a taxable commodity rather than a drug of abuse for most of the decade. Traditional healers continued to prescribe cannabis preparations within this system.

Algeria. Administered as an integral part of metropolitan France, Algeria followed stricter French domestic law. Cannabis was already restricted under French law, and this was enforced more uniformly than in the protectorates.

Tunisia. Tunisia occupied a middle position between the two, with French control less absolute than in Algeria and more regulatory than in Morocco.

Across all three territories, the 1925 Geneva Convention's adoption of cannabis export controls did not immediately trigger aggressive domestic enforcement. The impact on traditional medical practice remained limited during the 1920s itself; it was the architectural foundation for stricter national prohibitions that came in later decades.

How myths about 1920s cannabis medicine developed

Two persistent myths surround North African cannabis in this era.

Myth 1: "The 1925 Geneva Convention banned cannabis globally." It did not. The Convention brought Indian hemp under international export control and restricted it to medical and scientific purposes ^[6] Strong evidence. National prohibitions came later and varied enormously in scope and enforcement. Some nations banned cultivation entirely; others maintained medical or industrial use; Morocco maintained its licensed kif market for decades. The 1925 Convention was a regulatory framework, not a blanket prohibition.

Myth 2: "North African doctors led a heroic defense of medical cannabis at Geneva in the 1920s." There is minimal primary evidence for this. The most audible North African voice at the 1924–1925 conference was the Egyptian delegate arguing for control. The defense of cannabis medicine came primarily from British-Indian colonial administrators citing the 1894 Hemp Commission and from European pharmacists who wanted to keep Cannabis indica extracts in the pharmacopoeia ^[3] Strong evidence. North African physicians were largely absent from the diplomatic negotiations.

How the romance developed. The romantic image of 1920s Maghreb as an open haven of cannabis medicine is largely retrospective—constructed by later 20th-century writers, including Beat-era travelers and countercultural commentators in the 1950s and 1960s, projecting a countercultural fantasy onto a period that was actually characterized by tightening colonial control and international prohibitionist momentum Anecdote. Ethnographic and historical research in the late 20th century documented traditional use and brought it into wider awareness, but this documentation came decades after the 1920s themselves.

What the 1920s actually established

The 1920s in North Africa mattered less for medical advocacy and more for establishing the international legal architecture that would govern cannabis for the remainder of the 20th century and into the 21st.

The consequential event. Mohamed El Guindy's 1924–1925 Geneva intervention is the single most consequential North African cannabis policy event of the decade. His successful push to add cannabis to the international controlled substances list, despite methodologically weak evidence and substantive push-back from other delegations, redirected global cannabis policy toward prohibition rather than regulation ^[5], ^[6].

The regulatory counter-example. Morocco's state kif monopoly is the most interesting and durable counter-example—a functioning regulated market that predated modern cannabis legalization debates by nearly a century ^[8]. It demonstrates that a colonial administration chose revenue generation and social control over outright prohibition, and this model persisted long after the 1925 Convention.

The invisible practice. Traditional therapeutic use continued largely unchanged in villages and souks across North Africa, undocumented in any formal medical literature of the period, and only surfacing in ethnographic work and historical analysis decades later. This invisibility in official records does not mean it was absent; it means it was marginalized from the spaces where international policy was being made.

The 1920s closed with international architecture in place for cannabis control, but with North African practice, both medical and recreational, largely continuing as before—a disjunction between formal law and lived reality that characterized cannabis policy for the next hundred years.

Sources

How this page was made

Related

• Cannabis Activism in North Africa During the 1930s — Exploring the colonial cannabis monopoly, rural resistance, and the myths that followed.
• Cannabis Prohibition in Mexico in the 1920s — Mexico enacted one of the world's earliest cannabis bans in 1920, driven by domestic anti-...
• Cannabis Prohibition in South Asia During the 1920s — How the League of Nations, Egyptian diplomacy, and colonial revenue politics collided over...
• UN Drug Treaties and Cannabis — Three UN treaties control cannabis globally; legalization exists despite treaty language f...